[HTML][HTML] Circulating tumour DNA—looking beyond the blood

A Tivey, M Church, D Rothwell, C Dive… - Nature reviews clinical …, 2022 - nature.com
Over the past decade, various liquid biopsy techniques have emerged as viable alternatives
to the analysis of traditional tissue biopsy samples. Such surrogate 'biopsies' offer numerous …

[HTML][HTML] Exosome-based liquid biopsies in cancer: opportunities and challenges

W Yu, J Hurley, D Roberts, SK Chakrabortty… - Annals of …, 2021 - Elsevier
Liquid biopsy in cancer has gained momentum in clinical research and is experiencing a
boom for a variety of applications. There are significant efforts to utilize liquid biopsies in …

Screening for prostate cancer: US Preventive Services Task Force recommendation statement

DC Grossman, SJ Curry, DK Owens… - Jama, 2018 - jamanetwork.com
Importance In the United States, the lifetime risk of being diagnosed with prostate cancer is
approximately 11%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age …

The epidemiology of prostate cancer

CH Pernar, EM Ebot, KM Wilson… - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Prostate cancer is a major cause of disease and mortality among men, and each year 1.6
million men are diagnosed with and 366,000 men die of prostate cancer. In this review, we …

Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US

MR Cooperberg, W Meeks, R Fang, FD Gaylis… - JAMA network …, 2023 - jamanetwork.com
Importance Active surveillance (AS) is endorsed by clinical guidelines as the preferred
management strategy for low-risk prostate cancer, but its use in contemporary clinical …

[图书][B] Electrical impedance tomography: methods, history and applications

A Adler, D Holder - 2021 - books.google.com
With contributions from leading international researchers, this second edition of Electrical
Impedance Tomography: Methods, History and Applications has been fully updated …

The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities

MAR Mia, D Dey, MR Sakib, MY Biswas… - Phytotherapy …, 2023 - Wiley Online Library
Globally, prostate cancer (PCa) is regarded as a challenging health issue, and the number
of PCa patients continues to rise despite the availability of effective treatments in recent …

Ejaculation frequency and risk of prostate cancer: updated results with an additional decade of follow-up

JR Rider, KM Wilson, JA Sinnott, RS Kelly, LA Mucci… - European urology, 2016 - Elsevier
Background Evidence suggests that ejaculation frequency may be inversely related to the
risk of prostate cancer (PCa), a disease for which few modifiable risk factors have been …

[HTML][HTML] Phytochemicals in prostate cancer: from bioactive molecules to upcoming therapeutic agents

B Salehi, PVT Fokou, LRT Yamthe, BT Tali… - Nutrients, 2019 - mdpi.com
Prostate cancer is a heterogeneous disease, the second deadliest malignancy in men and
the most commonly diagnosed cancer among men. Traditional plants have been applied to …

Molecular imaging of prostate cancer

AG Wibmer, IA Burger, E Sala, H Hricak, WA Weber… - Radiographics, 2016 - pubs.rsna.org
Prostate cancer is the most common noncutaneous malignancy among men in the Western
world. The natural history and clinical course of prostate cancer are markedly diverse …